Dr Gabriella Rodolico

  • Lecturer in Science Education (Biology) (Education)

Biography

I am a Biotechnologist with a PhD in Pharmacological Science and physiopathology of the respiratory system from The Second University of Naples. In November 2007 I moved to Glasgow to complete my PhD at the Centre for Biophotonics, University of Strathclyde. In 2013 I decided to change my career due to personal circumstances. I attended the PGDE “Biology with Science” course at master level at University of Strathclyde. Since then I enjoyed teaching Biology with Science in the Secondary sector in Scotland. From 2013 to 2016, I worked for Glasgow City Council and then I moved to Glasgow Caledonian University teaching at the Advanced Higher HUB.

Through the years I developed a deep understanding of the Scottish educational system as opposite to the Italian Educational System. I became a fluent speaker in English and I developed an open growing mindset which led me to be particularly enthusiastic and keen to carry out challenging and exciting activities such as the ERASMUS exchange between teachers of different countries. 

In 2016 I received funding from the ERASMUS + and I went to Sweden to observe the Swedish Educational system. As a result I gained a broad overview of the Scottish Educational system as well as those of other countries and developed the expertise to bridge the gap that often is too wide between schools and Universities.

In May 2019 I took a step forward in my career and I started a new job as Lecturer in Science Education (Biology) at the School of Education, University of Glasgow.  Since then my main research interest has focused on the implementation of innovative technology in Initial Teacher Education courses such as Virtual Reality and the impact that it has on student teachers.

Publications

List by: Type | Date

Jump to: 2010 | 2009 | 2008
Number of items: 6.

2010

Martinelli, E. et al. (2010) Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells. Clinical Cancer Research, 16(20), pp. 4990-5001. (doi: 10.1158/1078-0432.CCR-10-0923) (PMID:20810384)

Ortolano, F., Maffia, P. , Dever, G., Rodolico, G. , Millington, O.R., De Simoni, M.G., Brewer, J.M. , Bushell, T.J., Garside, P. and Carswell, H.V. (2010) Advances in imaging of new targets for pharmacological intervention in stroke: real-time tracking of T-cells in the ischaemic brain. British Journal of Pharmacology, 159(4), pp. 808-811. (doi: 10.1111/j.1476-5381.2009.00527.x) (PMID:20015295) (PMCID:PMC2829206)

2009

Tucci, M., De Palma, R., Lombardi, L., Rodolico, G. , Berrino, L., Dammacco, F. and Silvestris, F. (2009) β3 integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells. Cancer Research, 69(16), pp. 6738-6746. (doi: 10.1158/0008-5472.CAN-09-0949) (PMID:19654300)

2008

Cascone, T., Morelli, M. P., Morgillo, F., Kim, W.‐Y., Rodolico, G. , Pepe, S., Berrino, L., Lee, H.‐Y., Heymach, J. V. and Ciardiello, F. (2008) Synergistic anti‐proliferative and pro‐apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti‐epidermal growth factor receptor (EGFR) drugs in human cancer cells. Journal of Cellular Physiology, 216(3), pp. 698-707. (doi: 10.1002/jcp.21444) (PMID:18381602)

Cosmi, L. et al. (2008) Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor. Journal of Experimental Medicine, 205(8), pp. 1903-1916. (doi: 10.1084/jem.20080397) (PMID:18663128) (PMCID:PMC2525581)

Piegari, E., Di Salvo, G., Castaldi, B., Vitelli, M. R., Rodolico, G. , Golino, P., Calabrò, R., Rossi, F. and Berrino, L. (2008) Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model. Ultrasound in Medicine and Biology, 34(3), pp. 370-378. (doi: 10.1016/j.ultrasmedbio.2007.08.002) (PMID:17935862)

This list was generated on Mon Oct 19 05:02:29 2020 BST.
Jump to: Articles
Number of items: 6.

Articles

Martinelli, E. et al. (2010) Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells. Clinical Cancer Research, 16(20), pp. 4990-5001. (doi: 10.1158/1078-0432.CCR-10-0923) (PMID:20810384)

Ortolano, F., Maffia, P. , Dever, G., Rodolico, G. , Millington, O.R., De Simoni, M.G., Brewer, J.M. , Bushell, T.J., Garside, P. and Carswell, H.V. (2010) Advances in imaging of new targets for pharmacological intervention in stroke: real-time tracking of T-cells in the ischaemic brain. British Journal of Pharmacology, 159(4), pp. 808-811. (doi: 10.1111/j.1476-5381.2009.00527.x) (PMID:20015295) (PMCID:PMC2829206)

Tucci, M., De Palma, R., Lombardi, L., Rodolico, G. , Berrino, L., Dammacco, F. and Silvestris, F. (2009) β3 integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells. Cancer Research, 69(16), pp. 6738-6746. (doi: 10.1158/0008-5472.CAN-09-0949) (PMID:19654300)

Cascone, T., Morelli, M. P., Morgillo, F., Kim, W.‐Y., Rodolico, G. , Pepe, S., Berrino, L., Lee, H.‐Y., Heymach, J. V. and Ciardiello, F. (2008) Synergistic anti‐proliferative and pro‐apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti‐epidermal growth factor receptor (EGFR) drugs in human cancer cells. Journal of Cellular Physiology, 216(3), pp. 698-707. (doi: 10.1002/jcp.21444) (PMID:18381602)

Cosmi, L. et al. (2008) Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor. Journal of Experimental Medicine, 205(8), pp. 1903-1916. (doi: 10.1084/jem.20080397) (PMID:18663128) (PMCID:PMC2525581)

Piegari, E., Di Salvo, G., Castaldi, B., Vitelli, M. R., Rodolico, G. , Golino, P., Calabrò, R., Rossi, F. and Berrino, L. (2008) Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model. Ultrasound in Medicine and Biology, 34(3), pp. 370-378. (doi: 10.1016/j.ultrasmedbio.2007.08.002) (PMID:17935862)

This list was generated on Mon Oct 19 05:02:29 2020 BST.